174 related articles for article (PubMed ID: 21129229)
1. Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.
Mahmood D; Grubbström M; Lundberg LD; Olivecrona G; Olivecrona T; Stegmayr BG
BMC Nephrol; 2010 Dec; 11():33. PubMed ID: 21129229
[TBL] [Abstract][Full Text] [Related]
2. Lipoprotein lipase activity is favoured by peritoneal dialysis compared to hemodialysis.
Mahmood D; Nilsson S; Olivecrona G; Stegmayr B
Scand J Clin Lab Invest; 2014 Jun; 74(4):296-300. PubMed ID: 24564630
[TBL] [Abstract][Full Text] [Related]
3. Lipoprotein lipase in hemodialysis patients: indications that low molecular weight heparin depletes functional stores, despite low plasma levels of the enzyme.
Näsström B; Stegmayr B; Olivecrona G; Olivecrona T
BMC Nephrol; 2004 Nov; 5():17. PubMed ID: 15527497
[TBL] [Abstract][Full Text] [Related]
4. Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center.
Lord H; Jean N; Dumont M; Kassis J; Leblanc M
Am J Nephrol; 2002; 22(1):58-66. PubMed ID: 11919404
[TBL] [Abstract][Full Text] [Related]
5. Lipoprotein lipase during heparin infusion: lower activity in hemodialysis patients.
Näsström B; Olivecrona G; Olivecrona T; Stegmayr BG
Scand J Clin Lab Invest; 2003; 63(1):45-53. PubMed ID: 12729069
[TBL] [Abstract][Full Text] [Related]
6. A single bolus of a low molecular weight heparin to patients on haemodialysis depletes lipoprotein lipase stores and retards triglyceride clearing.
Näsström B; Stegmayr B; Gupta J; Olivecrona G; Olivecrona T
Nephrol Dial Transplant; 2005 Jun; 20(6):1172-9. PubMed ID: 15797889
[TBL] [Abstract][Full Text] [Related]
7. Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.
Al-Saran KA; Sabry A; Taha M; Ghafour MA; Al Fawzan F
Saudi J Kidney Dis Transpl; 2010 Jan; 21(1):43-9. PubMed ID: 20061691
[TBL] [Abstract][Full Text] [Related]
8. Safety and Efficacy of Tinzaparin Anticoagulation during Nocturnal Hemodialysis.
Bugeja A; Harris S; McCormick B; Brown PA; Liberty C; Krepelka T; St-Cyr G; Akbari A
Am J Nephrol; 2019; 50(4):255-261. PubMed ID: 31434091
[TBL] [Abstract][Full Text] [Related]
9. Lower plasma levels of lipoprotein lipase after infusion of low molecular weight heparin than after administration of conventional heparin indicate more rapid catabolism of the enzyme.
Nasstrom B; Stegmayr BG; Olivecrona G; Olivecrona T
J Lab Clin Med; 2003 Aug; 142(2):90-9. PubMed ID: 12960955
[TBL] [Abstract][Full Text] [Related]
10. Comparison of two low-molecular weight heparins (LMWHs), tinzaparin and bemiparin, during hemodialysis.
Christidou FN; Frangia TK; Bamichas GI; Gionanlis LC; Natse TA; Georgoulis IE; Sombolos KI
Int J Clin Pharmacol Ther; 2005 Jul; 43(7):335-8. PubMed ID: 16035376
[TBL] [Abstract][Full Text] [Related]
11. Response of angiopoietin-like proteins 3 and 4 to hemodialysis.
Mahmood D; Makoveichuk E; Nilsson S; Olivecrona G; Stegmayr B
Int J Artif Organs; 2014 Jan; 37(1):13-20. PubMed ID: 24634330
[TBL] [Abstract][Full Text] [Related]
12. Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial.
Rodger MA; Ramsay T; MacKinnon M; Westphal M; Wells PS; McCormick B; Knoll G
Am J Kidney Dis; 2012 Sep; 60(3):427-34. PubMed ID: 22480794
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein lipase during continuous heparin infusion: tissue stores become partially depleted.
Näsström B; Olivecrona G; Olivecrona T; Stegmayr BG
J Lab Clin Med; 2001 Sep; 138(3):206-13. PubMed ID: 11528374
[TBL] [Abstract][Full Text] [Related]
14. Comparison of low molecular weight heparin to standard heparin in hemodialysis/hemofiltration.
Schrader J; Stibbe W; Armstrong VW; Kandt M; Muche R; Köstering H; Seidel D; Scheler F
Kidney Int; 1988 Apr; 33(4):890-6. PubMed ID: 2838681
[TBL] [Abstract][Full Text] [Related]
15. Effect of switching unfractionated heparin to low-molecular-weight heparin on serum potassium in hemodialysis patients.
Ezzatzadegan Jahromi S; Mahmoodi MS; Behroozi F; Roozbeh J; Emamghoreishi F
Iran J Kidney Dis; 2014 Nov; 8(6):475-80. PubMed ID: 25362223
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin supplement increases plasma lipoprotein lipase and hepatic triglyceride lipase levels in hemodialysis patients.
Goto T; Saika H; Takahashi T; Maeda A; Mune M; Yukawa S
Kidney Int Suppl; 1999 Jul; 71():S213-5. PubMed ID: 10412779
[TBL] [Abstract][Full Text] [Related]
17. Anticoagulation therapy during haemodialysis: a comparative study between two heparin regimens.
Sabry A; Taha M; Nada M; Al Fawzan F; Alsaran K
Blood Coagul Fibrinolysis; 2009 Jan; 20(1):57-62. PubMed ID: 20523166
[TBL] [Abstract][Full Text] [Related]
18. [Use of low molecular-weight heparin in hemodialysis patients].
Schrader J; Rieger J; Müschen H; Stibbe W; Köstering H; Kramer P; Scheler F
Klin Wochenschr; 1985 Jan; 63(2):49-55. PubMed ID: 3981950
[TBL] [Abstract][Full Text] [Related]
19. Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.
Hainer JW; Sherrard DJ; Swan SK; Barrett JS; Assaid CA; Fossler MJ; Cox DS; Williams RM; Pittenger AL; Stephenson CA; Hua TA
Am J Kidney Dis; 2002 Sep; 40(3):531-8. PubMed ID: 12200805
[TBL] [Abstract][Full Text] [Related]
20. Use of low-dose low molecular weight heparin in hemodialysis.
Lai KN; Wang AY; Ho K; Szeto CC; Li M; Wong LK; Yu AW
Am J Kidney Dis; 1996 Nov; 28(5):721-6. PubMed ID: 9158210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
